基于真实世界研究构建正清风痛宁致类风湿关节炎患者肝功能异常预测模型
本研究基于多中心真实世界数据,纳入1913例接受正清风痛宁治疗的类风湿关节炎患者,比较10种机器学习与深度学习模型,发现LightGBM模型预测肝功能异常性能最佳(准确率0.96,AUC 0.98)。研究还识别了与肝损伤相关的危险因素,包括高血脂、合并用药、吸烟、年龄和女性中年等。
要点
- LightGBM模型预测正清风痛宁致肝功能异常准确率达0.96,AUC达0.98。
- 高胆固醇、高甘油三酯、合并TNF-α抑制剂等可能增加肝损伤风险。
- 吸烟、高龄及45-65岁女性也与正清风痛宁致肝功异常相关。
核心结论
- LightGBM模型能有效预测正清风痛宁所致肝功能异常,有助于提高中西药联用安全性。
研究设计与样本
- 回顾性多中心真实世界研究,收集2018年1月至2023年4月数据,纳入1913例合格患者。
主要发现
- LightGBM模型表现最佳,准确率0.96;预测ALT<40 U/L的精确率0.99、召回率0.97、F1 0.98、AUC 0.98、敏感度0.97、特异度0.85。
- 预测40≤ALT<80 U/L的精确率0.60、召回率0.83、F1 0.70、AUC 0.98、敏感度0.83、特异度0.97。
- 预测ALT≥80 U/L的精确率0.83、召回率0.63、F1 0.71、AUC 0.97、敏感度0.63、特异度1.00。
- 正清风痛宁致肝功能异常与高总胆固醇、高甘油三酯、合并TNF-α抑制剂、JAK抑制剂、甲氨蝶呤+非甾体抗炎药、来氟米特、吸烟、高龄及中年女性(45-65岁)相关。
临床怎么用
- 对使用正清风痛宁的类风湿关节炎患者,可借助LightGBM模型评估肝损伤风险。
- 对合并高血脂、特定用药、吸烟、高龄或中年女性等高危因素者,应加强肝功能监测。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Rheumatoid arthritis (RA) is a systemic autoimmune disease that affects the small joints of the whole body and degrades the patients' quality of life. Zhengqing Fengtongning (ZF) is a traditional Chinese medicine preparation used to treat RA. ZF may cause liver injury. In this study, we aimed to develop a prediction model for abnormal liver function caused by ZF. METHODS: This retrospective study collected data from multiple centers from January 2018 to April 2023. Abnormal liver function was set as the target variable according to the alanine transaminase (ALT) level. Features were screened through univariate analysis and sequential forward selection for modeling. Ten machine learning and deep learning models were compared to find the model that most effectively predicted liver function from the available data. RESULTS: This study included 1,913 eligible patients. The LightGBM model exhibited the best performance (accuracy = 0.96) out of the 10 learning models. The predictive metrics of the LightGBM model were as follows: precision = 0.99, recall rate = 0.97, F1_score = 0.98, area under the curve (AUC) = 0.98, sensitivity = 0.97 and specificity = 0.85 for predicting ALT < 40 U/L; precision = 0.60, recall rate = 0.83, F1_score = 0.70, AUC = 0.98, sensitivity = 0.83 and specificity = 0.97 for predicting 40 ≤ ALT < 80 U/L; and precision = 0.83, recall rate = 0.63, F1_score = 0.71, AUC = 0.97, sensitivity = 0.63 and specificity = 1.00 for predicting ALT ≥ 80 U/L. ZF-induced abnormal liver function was found to be associated with high total cholesterol and triglyceride levels, the combination of TNF-α inhibitors, JAK inhibitors, methotrexate + nonsteroidal anti-inflammatory drugs, leflunomide, smoking, older age, and females in middle-age (45-65 years old). CONCLUSION: This study developed a model for predicting ZF-induced abnormal liver function, which may help improve the safety of integrated administration of ZF and Western medicine. Please cite this article as: Yu Z, Kou F, Gao Y, Lyu CM, Gao F, Wei H. A machine learning model for predicting abnormal liver function induced by a Chinese herbal medicine preparation (Zhengqing Fengtongning) in patients with rheumatoid arthritis based on real-world study. J Integr Med. 2025; 23(1): 25-35.
引用
- Yu Z, Kou F, Gao Y, et al. A machine learning model for predicting abnormal liver function induced by a Chinese herbal medicine preparation (Zhengqing Fengtongning) in patients with rheumatoid arthritis based on real-world study. J Integr Med. 2024. PMID: 39721810. doi:10.1016/j.joim.2024.12.001
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。